SPP1 and neoplasm: Results of this study showed promising relative risk that support the clinical activity of oral TJ-107 against OPN, particularly acute cold-associated neuropathy, in patients who received FOLFOX therapy (FOLFOX4 or mFOLFOX6) for colorectal cancer without imposing negative impact on oxaliplatin-based anti-tumor effect.